Mendus AB: Mendus AB (publ) interim report April – June 2022
Progress made throughout the second quarter puts the company in a strong position to deliver…
Progress made throughout the second quarter puts the company in a strong position to deliver…
REGULATED INFORMATION Preliminary documents for the Extraordinary General Meeting have been made available on company’s…
Mendus AB (“Mendus” publ; IMMU.ST), a biopharmaceutical company addressing tumor recurrence through cell-based immunotherapies, today…
Vancouver, British Columbia–(Newsfile Corp. – August 26, 2022) – Adamant Global Holding (CSE: ADMT) (OTC…
TOKYO, Aug 26, 2022 – (JCN Newswire) – Mitsubishi Corporation (MC) is pleased to announce…
HONG KONG, Aug 26, 2022 – (ACN Newswire) – On August 24, Wuling Motors (00305.HK),…
NEW CASTLE, Del.–(BUSINESS WIRE)–FS.COM, the high-speed communication solution provider for data centers, enterprises, and telecom…
— the 7th innovative drug in Junshi Biosciences’ pipeline to get IND approval from the…
Internet City, Dubai–(Newsfile Corp. – August 25, 2022) – LBank Exchange, a global digital asset…
Toronto, Ontario–(Newsfile Corp. – August 25, 2022) – DelphX Capital Markets Inc. (TSXV: DELX) (OTCQB:…
Vancouver, British Columbia–(Newsfile Corp. – August 25, 2022) – Coloured Ties Capital Inc. (TSXV: TIE)…
One-day workshops in Mumbai and Delhi focus on technology and cybersecurity benefits of cloud video…
ATLANTA & NEW YORK–(BUSINESS WIRE)–Intercontinental Exchange, Inc. (NYSE: ICE), a leading global provider of data,…
TORONTO, Aug. 25, 2022 (GLOBE NEWSWIRE) — Blueberries Medical Corp. (CSE: BBM) (OTC: BBRRF) (FRA:…
SOMERVILLE, Mass., Aug. 25, 2022 (GLOBE NEWSWIRE) — Finch Therapeutics Group, Inc. (“Finch” or “Finch…
SAN DIEGO, Aug. 25, 2022 (GLOBE NEWSWIRE) — Travere Therapeutics, Inc. (NASDAQ: TVTX) today announced…
Significant Milestones Achieved WINNIPEG, Manitoba, Aug. 25, 2022 (GLOBE NEWSWIRE) — Kane Biotech Inc. (TSX-…
Dr. Heron brings decades of experience in executive leadership and life sciences research and development…
SALT LAKE CITY, Aug. 25, 2022 (GLOBE NEWSWIRE) — Myriad Genetics, Inc., (NASDAQ: MYGN), a…
WALTHAM, Mass., Aug. 25, 2022 (GLOBE NEWSWIRE) — Viridian Therapeutics, Inc. (NASDAQ: VRDN), a biotechnology…